These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25997536)

  • 21. Berberine-induced anticancer activities in FaDu head and neck squamous cell carcinoma cells.
    Seo YS; Yim MJ; Kim BH; Kang KR; Lee SY; Oh JS; You JS; Kim SG; Yu SJ; Lee GJ; Kim DK; Kim CS; Kim JS; Kim JS
    Oncol Rep; 2015 Dec; 34(6):3025-34. PubMed ID: 26503508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD44(high) /ALDH1(high) head and neck squamous cell carcinoma cells exhibit mesenchymal characteristics and GSK3β-dependent cancer stem cell properties.
    Seino S; Shigeishi H; Hashikata M; Higashikawa K; Tobiume K; Uetsuki R; Ishida Y; Sasaki K; Naruse T; Rahman MZ; Ono S; Simasue H; Ohta K; Sugiyama M; Takechi M
    J Oral Pathol Med; 2016 Mar; 45(3):180-8. PubMed ID: 26399460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel C-Terminal Heat Shock Protein 90 Inhibitors (KU711 and Ku757) Are Effective in Targeting Head and Neck Squamous Cell Carcinoma Cancer Stem cells.
    Subramanian C; Kovatch KJ; Sim MW; Wang G; Prince ME; Carey TE; Davis R; Blagg BSJ; Cohen MS
    Neoplasia; 2017 Dec; 19(12):1003-1011. PubMed ID: 29121598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Plasma Activated Medium on Head and Neck FaDu Cancerous Cells: Comparison of 3D and 2D Response.
    Chauvin J; Judee F; Merbahi N; Vicendo P
    Anticancer Agents Med Chem; 2018; 18(6):776-783. PubMed ID: 28762317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor associated macrophages induce epithelial to mesenchymal transition via the EGFR/ERK1/2 pathway in head and neck squamous cell carcinoma.
    Gao L; Zhang W; Zhong WQ; Liu ZJ; Li HM; Yu ZL; Zhao YF
    Oncol Rep; 2018 Nov; 40(5):2558-2572. PubMed ID: 30132555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of tumor progression via the Snail-RKIP signaling pathway by nicotine exposure in head and neck squamous cell carcinoma.
    Nieh S; Jao SW; Yang CY; Lin YS; Tseng YH; Liu CL; Lee TY; Liu TY; Chu YH; Chen SF
    Head Neck; 2015 Dec; 37(12):1712-21. PubMed ID: 24986226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. G9a is essential for EMT-mediated metastasis and maintenance of cancer stem cell-like characters in head and neck squamous cell carcinoma.
    Liu S; Ye D; Guo W; Yu W; He Y; Hu J; Wang Y; Zhang L; Liao Y; Song H; Zhong S; Xu D; Yin H; Sun B; Wang X; Liu J; Wu Y; Zhou BP; Zhang Z; Deng J
    Oncotarget; 2015 Mar; 6(9):6887-901. PubMed ID: 25749385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Priming hMSCs with a putative anti-cancer compound, myrtucommulone-a: a way to harness hMSC cytokine expression via modulating PI3K/Akt pathway?
    Iskender B; Izgi K; Sakalar C; Canatan H
    Tumour Biol; 2016 Feb; 37(2):1967-81. PubMed ID: 26334623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-6 Inhibition With MEDI5117 Decreases The Fraction of Head and Neck Cancer Stem Cells and Prevents Tumor Recurrence.
    Finkel KA; Warner KA; Kerk S; Bradford CR; McLean SA; Prince ME; Zhong H; Hurt EM; Hollingsworth RE; Wicha MS; Tice DA; Nör JE
    Neoplasia; 2016 May; 18(5):273-281. PubMed ID: 27237319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Additive antitumor effects of celecoxib and simvastatin on head and neck squamous cell carcinoma in vitro.
    Gehrke T; Scherzad A; Hackenberg S; Ickrath P; Schendzielorz P; Hagen R; Kleinsasser N
    Int J Oncol; 2017 Sep; 51(3):931-938. PubMed ID: 28713941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The upregulated α-catulin expression was involved in head-neck squamous cell carcinogenesis by promoting proliferation, migration, invasion, and epithelial to mesenchymal transition.
    Zhang Z; Yang XF; Huang KQ; Ren L; Zhao S; Gou WF; Shen DF; Sun HZ; Takano Y; Zheng HC
    Tumour Biol; 2016 Feb; 37(2):1671-81. PubMed ID: 26311049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EGFR antisense treatment of human HNSCC cell lines down-regulates VEGF expression and endothelial cell migration.
    Riedel F; Götte K; Li M; Hörmann K; Grandis JR
    Int J Oncol; 2002 Jul; 21(1):11-6. PubMed ID: 12063543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mesenchymal stem cell-derived interleukin-6 and vascular endothelial growth factor promote breast cancer cell migration.
    De Luca A; Lamura L; Gallo M; Maffia V; Normanno N
    J Cell Biochem; 2012 Nov; 113(11):3363-70. PubMed ID: 22644871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cell carcinoma.
    Kakuki T; Kurose M; Takano K; Kondoh A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Takahashi S; Hatakeyama T; Kohno T; Himi T; Kojima T
    Oncotarget; 2016 Jun; 7(23):33887-900. PubMed ID: 27036044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor suppressive microRNA-133a regulates novel targets: moesin contributes to cancer cell proliferation and invasion in head and neck squamous cell carcinoma.
    Kinoshita T; Nohata N; Fuse M; Hanazawa T; Kikkawa N; Fujimura L; Watanabe-Takano H; Yamada Y; Yoshino H; Enokida H; Nakagawa M; Okamoto Y; Seki N
    Biochem Biophys Res Commun; 2012 Feb; 418(2):378-83. PubMed ID: 22266319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting FAK radiosensitizes 3-dimensional grown human HNSCC cells through reduced Akt1 and MEK1/2 signaling.
    Hehlgans S; Eke I; Cordes N
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e669-76. PubMed ID: 22483702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of TRIM24 Stimulates Proliferation and Glucose Metabolism of Head and Neck Squamous Cell Carcinoma.
    Wang H; Xue W; Jiang X
    Biomed Res Int; 2018; 2018():6142843. PubMed ID: 29862279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spheroid-based 3-dimensional culture models: Gene expression and functionality in head and neck cancer.
    Schmidt M; Scholz CJ; Polednik C; Roller J
    Oncol Rep; 2016 Apr; 35(4):2431-40. PubMed ID: 26797047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesenchymal stem cells are enriched in head neck squamous cell carcinoma, correlates with tumour size and inhibit T-cell proliferation.
    Liotta F; Querci V; Mannelli G; Santarlasci V; Maggi L; Capone M; Rossi MC; Mazzoni A; Cosmi L; Romagnani S; Maggi E; Gallo O; Annunziato F
    Br J Cancer; 2015 Feb; 112(4):745-54. PubMed ID: 25647013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments.
    Albanell J; Codony-Servat J; Rojo F; Del Campo JM; Sauleda S; Anido J; Raspall G; Giralt J; Roselló J; Nicholson RI; Mendelsohn J; Baselga J
    Cancer Res; 2001 Sep; 61(17):6500-10. PubMed ID: 11522647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.